Results 121 to 130 of about 19,762 (141)

CHK1 inhibition overcomes gemcitabine resistance in non-small cell lung cancer cell A549. [PDF]

Mol Cell Oncol
Ke ZY, Fu T, Wang XC, Ma X, Yin HH, Wang WX, Liu YJ, Liang AL.   +7 more
europepmc   +1 more source

Cyclin A2 regulates homologous recombination DNA repair and sensitivity to DNA damaging agents and poly(ADP-ribose) polymerase (PARP) inhibitors in human breast cancer cells. [PDF]

Oncotarget, 2017
Gu WW, Lin J, Hong XY.
europepmc   +1 more source

Adipose-derived small extracellular vesicle miR-146a-5p targets Fbx32 to regulate mitochondrial autophagy and delay aging in skeletal muscle. [PDF]

J Nanobiotechnology
Qin M, Wang Y, Wang Z, Dong B, Yang P, Liu Y, Xi Q, Ma J.   +7 more
europepmc   +1 more source

CDK-mediated phosphorylation of PNKP is required for end-processing of single-strand DNA gaps on Okazaki fragments and genome stability. [PDF]

Elife
Tsukada K, Imamura R, Miyake T, Saikawa K, Saito M, Kase N, Fu L, Ishiai M, Matsumoto Y, Shimada M.   +9 more
europepmc   +1 more source

Carfilzomib inhibits the progression of hepatocellular cancer by upregulating GADD45α expression. [PDF]

Oncol Lett
Chen M, Chen X, Shui Y, Ji C, Guo W.
europepmc   +1 more source

Adipose-derived exosomes ameliorate skeletal muscle atrophy via miR-146a-5p/IGF-1R signaling. [PDF]

J Nanobiotechnology
Qin M, Zhu J, Xing L, Fan Y, Luo J, Sun J, Chen T, Zhang Y, Xi Q.   +8 more
europepmc   +1 more source

HOXA1 Contributes to Bronchial Epithelial Cell Cycle Progression by Regulating p21/CDKN1A. [PDF]

Int J Mol Sci
McCluskey E, Velli SK, Kaminski R, Markward T, Leming H, Yu D, Sajjan U.   +6 more
europepmc   +1 more source

Monomeric and heterodimeric differential phosphorylation pattern in the Cyclin- A2/CDK2 complex

, 2008
Casado-Vela, Juan, Martínez, J., Romero, S., Casal, Ignacio   +3 more
openaire   +1 more source

High-throughput discovery and deep characterization of cyclin-CDK docking motifs

Örd M, Winters MJ, Subbanna MS, de Martin Garrido N, Cushing VI, Kliche J, Benz C, Ivarsson Y, Greber BJ, Pryciak PM, Davey NE.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer

Oncology Research and Treatment, 2023
Introduction: Small cell lung cancer (SCLC) is a special type of lung cancer sensitive to radiotherapy and chemotherapy but is prone to drug resistance and recurrence and has a very poor prognosis. This study aimed to explore the potential biomarkers and therapeutic targets for SCLC. Methods: After batch normalization of GSE40275, GSE1037, and GSE44447
Xiangxin Zhang, Liu Yang, Bing Huang, Jiangwen Yin, Yutao Wei   +4 more
openaire   +2 more sources